NIDA-CTN-0029

Division
CTN
HEAL Study
No
Investigator(s)
T. John Winhusen, Ph.D.
Eugene Somoza, M.D.
Title
A Pilot Study of Osmotic-Release Methylphenidate in Initiating and Maintaining Abstinence in Smokers with ADHD
Short Description
The main study objective was to evaluate whether OROS MPH compared to placebo increases the effectiveness of standard smoking treatment in obtaining prolonged abstinence for smokers with ADHD.
Release Date
Dec 15, 2009
Description

Adult ADHD is a common and impairing neuro-psychiatric disorder, affecting approximating seven to eight millions adults in the United States. Substance use disorders, including cigarette smoking and nicotine dependence, are some of the more common co-morbid disorders with adult ADHD. Studies have found that adults with ADHD are twice as likely to smoke cigarettes and be dependent on nicotine than adults without ADHD.

Keywords
adhd
oros-mph
smoking
Assessments
Adult ADHD Self Report Rating Scale
Adult Clinician Diagnostic Scale
Beck Anxiety Inventory
Beck Depression Inventory
Clinical Global Impression Scales
Composite International Diagnostic Interview for DSM-IV
DSM-IV -Antisocial Personality Disorder Screening
DSM-IV ADHD Symptom Checklist
Drug Rating Questionnaire
Fagerstrom Test for Nicotine Dependence
Psychiatric Research Interview for Substance and Mental Disorders
Smoking Cessation Counseling
Smoking History Survey
Thoughts About Abstinence
Tobacco Use Assessment
Withdrawal Scale for Tobacco
Accessibility Notice

Please note that the supplementary documents may not be fully Section 508 compliant. Please contact us for assistance.

Study Data
CTN-0029 Data
Study Links
Primary Manuscript
CTN-0029 Primary Manuscript
Study Information
CTN-0029 Study Information
ClinicalTrials.gov Link
Clinical Trials .gov link
Study Documents
Protocol
0029.pdf
Case Report Form(s)
annotated_crf_nida-ctn-0029.pdf
Deidentification Notes
study_specific_de_identification_notes_nida-ctn-0029.pdf
All Documents
CTN-0029-all-documents.zip